Liechtenstein vs North Macedonia: Cervical cancer screening coverage in Europe
Liechtenstein
34.3%
in 2022
North Macedonia
22.4%
in 2021
Liechtenstein rank
17th
North Macedonia rank
20th
Cervical cancer screening coverage in Europe over time
- Liechtenstein
- North Macedonia
How they compare
Liechtenstein currently reports 34.3% against 22.4% in North Macedonia, a difference of 11.9%.
That makes Liechtenstein's figure about 1.5 times North Macedonia's.
Across all 6 years both countries report, Liechtenstein has been ahead every year.
Liechtenstein ranks 17th and North Macedonia ranks 20th of 23 countries.
Liechtenstein has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Liechtenstein | North Macedonia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 29.2% | 11.8% | 17.5% | Liechtenstein |
| 2020s | 26.8% | 14.0% | 12.7% | Liechtenstein |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cervical cancer screening coverage in europe, Liechtenstein or North Macedonia?
- Liechtenstein, at 34.3% against 22.4% in North Macedonia as of 2022.
- What is the difference in cervical cancer screening coverage in europe between Liechtenstein and North Macedonia?
- 11.9%, with Liechtenstein ahead.
- How many years of comparable data are there for Liechtenstein and North Macedonia?
- 6 years are reported by both, from 2014 to 2021.
- How do Liechtenstein and North Macedonia rank globally for cervical cancer screening coverage in europe?
- Liechtenstein ranks 17th and North Macedonia ranks 20th of 23 countries.
- Where does this data come from?
- Eurostat (2024) – processed by Our World in Data, published as Cervical cancer screening coverage in Europe. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Share of women aged 20 to 69 years who have been screened for cervical cancer within the previous 3 years.